User experienced slow gains with topical fin+min, switched to topical dut+min, and considered adding Eucapil. Another user suggested DUT may be less effective topically due to high molar mass and mentioned Fluridil as a weak anti-androgen that could help.
A user with alopecia areata is considering treatment options like injections or Olumiant but is concerned about cost and whether delaying treatment will lead to permanent hair loss. They are seeking alternative treatments that are more affordable for a college student.
The user experienced reduced effectiveness of minoxidil after consistent use, despite using dutasteride to maintain hair. They are considering alternatives like microneedling and exploring options like hair transplants due to dissatisfaction with current hair density.
User is experiencing scalp itch and hair loss despite using Nizoral, Minoxidil, derma rolling, and Finasteride for 6 months. They are considering switching to Dutasteride.
The user has been losing hair since age 12 and is now starting treatment with 0.5 mg dutasteride and 2.5 mg minoxidil at age 29. They have also experienced dandruff and have a thinning crown.
A 28-year-old male experienced significant hair regrowth using dutasteride 0.5 mg and 2.5 mg oral minoxidil after previous treatments with minoxidil and finasteride became less effective. He reported no major side effects, except for unwanted hair growth in certain areas.
NAD⁺ precursors and EGCG may increase hair density, but users report mixed results with no significant hair gains. Some users suggest combining these with finasteride or dutasteride for better results.
The conversation discusses using Sandalore for hair loss treatment, with a focus on finding the correct concentration for a topical lotion. The consensus is to start with a 0.1% concentration due to potential scalp irritation at higher levels.
The conversation is about comparing the effectiveness of adenosine and minoxidil for treating hair loss. People are sharing their thoughts and experiences on which is better.